| Autor: |
Maggio J; Molecular Oncology Unit, Center of Molecular and Translational Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Buenos Aires B1876BXD, Argentina., Cardama GA; Antitumor Drug Evaluation and Development Unit, Center of Molecular and Translational Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Buenos Aires B1876BXD, Argentina., Armando RG; Molecular Oncology Unit, Center of Molecular and Translational Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Buenos Aires B1876BXD, Argentina., Balcone L; Molecular Oncology Unit, Center of Molecular and Translational Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Buenos Aires B1876BXD, Argentina., Sobol NT; Translational Oncology Unit, Center of Molecular and Translational Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Buenos Aires B1876BXD, Argentina., Gomez DE; Molecular Oncology Unit, Center of Molecular and Translational Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Buenos Aires B1876BXD, Argentina., Mengual Gómez DL; Molecular Oncology Unit, Center of Molecular and Translational Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Buenos Aires B1876BXD, Argentina. |
| Abstrakt: |
PIN1 is the only known enzyme capable of recognizing and isomerizing the phosphorylated Serine/Threonine‑Proline motif. Through this mechanism, PIN1 controls diverse cellular functions, including telomere maintenance. Both PIN1 overexpression and its involvement in oncogenic pathways are involved in several cancer types, including glioblastoma (GBM), a lethal disease with poor therapeutic resources. However, knowledge of the role of PIN1 in GBM is limited. Thus, the present work aimed to study the role of PIN1 as a telomere/telomerase regulator and its contribution to tumor biology. PIN1 knockout (KO) LN‑229 cell variant using CRISPR/Cas9 was developed and compared with PIN1 LN‑229 expressing cells. To study the effect of PIN1 absence, status of NF‑κB pathway was evaluated by luciferase reporter gene assay and quantitative PCR. Results revealed that PIN1 deletion in GBM cells diminished the active levels of NF‑κB and decrease the transcription of il‑8 and htert genes. Then, telomere/telomerase related processes were studied by RQ‑TRAP assay and telomere length determination by qPCR, obtaining a reduction both in telomerase activity as in telomere length in PIN1 KO cells. In addition, measurement of SA β‑galactosidase and caspase‑3 activities revealed that loss of PIN1 triggers senescence and apoptosis. Finally, migration, cell cycle progression and tumorigenicity were studied by flow cytometry/western blot, Transwell assay and in vivo experiments, respectively. PIN1 deletion decreased migration as well as cell cycle progression by increasing doubling time and also resulted in the loss of LN‑229 cell ability to form tumors in mice. These results highlight the role of PIN1 in telomere homeostasis and GBM progression, which supports PIN1 as a potential molecular target for the development of novel therapeutic agents for GBM treatment. |
